Healthcare Contract Development and Manufacturing Organization Market

Healthcare Contract Development and Manufacturing Organization Market by Service (Contract Development, Contract Manufacturing) and by Region (North America, Latin America, Europe, APAC, MEA) - 2022 to 2032

Newly-released Healthcare Contract Development and Manufacturing Organization market analysis report by Transparency Market Research shows that global sales of the market for Healthcare Contract Development and Manufacturing Organization in 2021 was held at US$ 221.1 Bn. With an 11.6% CAGR during 2022 - 2032, the projected market growth is expected to reach a valuation of US$ 723.6 Bn. The absolute dollar opportunity for the Healthcare CDMO market will be US$ 479.6 Bn during 2022 – 2032.

Revenue of the Healthcare Contract Development and Manufacturing Organization (CDMO) market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Healthcare Contract Development and Manufacturing Organization market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Healthcare Contract Development and Manufacturing Organization (CDMO) market increased at around 9.8% CAGR. Countries such as the U.S., China, Japan, the U.K., and South Korea held a significant share of the global market.

Healthcare contract development and manufacturing organizations render outsourcing services to several pharmaceutical industries on a contract basis. To reduce operational and capital expenses, the pharmaceutical industries look for healthcare contract development and manufacturing organizations to a large extent. Owing to this, Contract Development and Manufacturing Organization market is projected to grow at a CAGR of 11.6% over the coming 10 years.

What will be the growth prospects of the Healthcare Contract Development and Manufacturing Organization Market?

Regulations regarding the synthesis and development of generic medicine and biologics have created a significant demand for medical services and the need for various manufacturing procedures. This has also motivated many pharmaceutical companies to approach healthcare organizations and healthcare organizations to sustain the supply and demand for medical activities.

The biopharmaceuticals, medical operations, and devices found in the pharma industries led to increased complexity in operations and the supply chain that make companies more likely to contract manufacture and develop. In March of 2021, Fujifilm Diosynth Biotechnologies selected Holly Springs, North Carolina, for its new site with a ¥200-billion capacity.

Which Region is projected to Offer the Largest Opportunity for Healthcare CDMO Market?

With over 13.6% and 13.2% projected growth rates in Japan and China respectively, Healthcare Contract Development and Manufacturing Organization market revenue are expected to grow at the fastest pace in the Asia Pacific, during 2022 - 2032. Some of the key companies having manufacturing units at prominent locations in APAC have started to expand their production units to different locations of APAC to distribution efficiency. While this implies a shift in the diversification of global locations, it promises a significant opportunity for the global market.

Country-wise Analysis

U.S. Healthcare Contract Development and Manufacturing Organization (CDMO) Market Analysis

The US dominated the global Healthcare CDMO market and is poised to reach US$ 275.6 Bn by 2032. The growing number of hospital admission and ease of medicare reimbursement policy drives the demand for medical drugs and activities to a significant extent, thus to meet the requirement in the stipulated time the companies approach the CDMO.

U.K. Healthcare Contract Development and Manufacturing Organization Market Analysis

The Healthcare CDMO Market in the U.K. stood at US$ 8.5 Bn in 2021. The market is projected to reach a valuation of US$ 24.2 Bn by 2032. The market in the country is expected to gross an absolute dollar opportunity of US$ 14.9 Bn during 2022 – 2032, growing at a CAGR of 10%.

Japan Healthcare CDMO Market Analysis

The Healthcare CDMO Market in Japan is estimated at US$ 9.5 Bn in 2022. The market is projected to reach a valuation of US$ 34.2 Bn by 2032. With a projected CAGR of 13.6% during 2022 – 2032, the market is projected to score an absolute dollar opportunity of US$ 24.6 Bn.

South Korea Healthcare Contract Development and Manufacturing Organization Market Analysis

The market for Healthcare CDMO in South Korea is expected to garner a market size of US$ 22.8 Bn by 2032, growing at a CAGR of 13.7% during 2022 – 2032. During this period, the market is expected to garner an absolute dollar opportunity of US$ 16.4 Bn.

Category-wise Insights

Which Services of Healthcare Contract Development and Manufacturing Organizations are in High demand?

Pharmaceutical and medical device manufacturers plan to outsource to reduce manufacturing expenses. It enables manufacturers to be more dynamic and cost-effective in their manufacturing procedures, allowing for the development of new medical drugs and devices. These materials were used as a result of recent and minimally invasive surgical procedures. The rapid surge in demand will be met by outsourcing manufacturing activities.

COVID-19 pushed companies to increase the manufacturing of drugs and devices. The US FDA statistics show that 60% of the medical manufacturing activities are coming from China to meet the demand for drugs in the stipulated time. However, during the pandemic, the supply chain of China's medical manufacturing activities was totally disrupted.

The shortage created a demand for the manufacturing of active pharmaceutical ingredients (APIs) in order to maintain supply. Based on a 2020 Global Managed Services Report, nearly 45% of organizations will outsource more in the coming years. The sub-services of contract manufacturing are Small molecules, Large Molecules, High Potency API, Finished Dose Formulations, and Medical Devices.

Why have sub-services like medical devices in Contract Manufacturing Organizations captured significant demand?

Device manufacturing sub-services captured more market share than other services. Due to the lack of in-house manufacturing units, there is utmost demand for the manufacturing of medical devices. The medical device segment is segregated into cardiology, orthopedic, general and plastic surgery, drug delivery, dental, endoscopy, diabetes care, ophthalmic, diagnostic imaging, and other areas. Cardiological devices have high demand due to the rapid surge of cardiovascular diseases in old age people.

How Has COVID-19 Impacted Healthcare Contract Development and Manufacturing Organization market?

The COVID-19 pandemic has significantly impacted every industry in the world. However, the Healthcare Contract Development and Manufacturing Organization (CDMO) observed positive growth during the pandemic. Contract manufacturing met the essential needs of the pharmaceutical industries and others during the pandemic. During the pandemic, CDMO provided pharma, biotech, and other companies with time-saving, cost-effective services. The surge in demand for COVID -19 essential vaccines and drugs led to the growth of the healthcare CDMO market during the pandemic.

Competitive Analysis

Some of the key companies in the healthcare CDMO Market include Catalent Inc., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, and Thermo Fisher Scientific Inc.

Some of the recent developments in the Healthcare Contract Development and Manufacturing Organization market are:

  • In May 2019, Catalent Inc. acquired Paragon Bioservices Inc. for US$ 1.2 Bn. This acquisition will enable Catalent to gain a US$ 40 Bn addressable market for gene therapies.
  • In February 2022, Recipharm acquired Vibalogics, Arranta Bio, and Recipharm’s advanced therapy medicinal products offerings into virotherapy and its biologics offerings in the U.S.
  • In February 2022, Pharma Nobis, LLC completed the acquisition of Fagron’s contract manufacturing business and manufacturing facility.
  • In February 2022, Cytiva and NecstGen collaborated on the development of cell and gene therapies.
  • In February 2022, Australia's Beroni Group opened its first R&D facility in China.

Market Segments Covered in Healthcare CDMO Industry Analysis

By Services

  • Contract Development
    • Small Molecule
    • Large Molecule
    • Shockwave Therapy
  • Contract Manufacturing
    • Small Molecule
    • Large Molecule
    • High Potency API
    • Finished Dose Formulations
    • Medical Devices

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Global Market Snapshot

Attribute

Details

Global Healthcare CDMO Market (2022)

US$ 243.9 Bn

Global Healthcare CDMO Industry (2032)

US$ 723.6 Bn

Global Market CAGR (2022 – 2032)

11.6%

U.S. Healthcare CDMO Market (2022)

US$ 85 Bn

Key Companies Profiled

  • Catalent Inc.
  • Lonza Group Ltd.
  • Recipharm AB
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Covance Inc.
  • Jabil
  • Sanmina Corporation
  • IQVIA Holdings Inc.
  • Flex

Frequently Asked Questions

How much is the current worth of the Healthcare Contract Development and Manufacturing Organization market?

The global Healthcare Contract Development and Manufacturing Organization (CDMO) market is worth more than US$ 243.9 Bn at present.

What is the sales forecast for Healthcare Contract Development and Manufacturing Organization market?

The value of the Healthcare CDMO market is projected to increase at a CAGR of around 11.6% during 2022 – 2032.

What was the last 5 year’s market CAGR?

The value of Healthcare Contract Development and Manufacturing Organization increased at a CAGR of around 9.8% during 2017 – 2021.

Which are the top 5 countries driving demand for Healthcare Contract Development and Manufacturing Organization?

The top 5 countries driving demand for Healthcare Contract Development and Manufacturing Organization market are the U.S., China, Japan, the UK, and South Korea.

What is the forecast for the market in North America?

Healthcare Contract Development and Manufacturing Organization (CDMO) market in North America will grow at 12.8% CAGR during 2022-2032.

Which is the top country for Healthcare Contract Development and Manufacturing Organizations?

The US market for Healthcare Contract Development and Manufacturing Organization is accumulated larger market share and will expand at a CAGR of around 12.6% during 2022 – 2032.

Who are the key players for Healthcare Contract Development and Manufacturing Organization?

The major players are Catalent Inc., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, and Thermo Fisher Scientific Inc.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Healthcare Contract Development And Manufacturing Organization Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Healthcare Contract Development And Manufacturing Organization Market (US$ Mn)

    4.2. Healthcare Contract Development And Manufacturing Organization Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Healthcare Contract Development And Manufacturing Organization Market Growth

        4.5.3. Healthcare Contract Development And Manufacturing Organization Adoption Rate, by Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Healthcare Contract Development And Manufacturing Organization Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Healthcare Contract Development And Manufacturing Organization Market Demand Analysis 2017-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2017-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Healthcare Contract Development And Manufacturing Organization Market Value Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Services

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Services , 2017-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Services , 2022-2032

        8.3.1. Contract Development

            8.3.1.1. Small Molecule

            8.3.1.2. Large Molecule

            8.3.1.3. Shockwave Therapy

        8.3.2. Contract Manufacturing

            8.3.2.1. Small Molecule

            8.3.2.2. Large Molecule

            8.3.2.3. High Potency API

            8.3.2.4. Finished Dose Formulations

            8.3.2.5. Medical Devices

    8.4. Market Attractiveness Analysis By Services

9. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Services

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Services

11. Latin America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Services

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Services

12. Europe Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. U.K.

            12.4.1.4. Italy

            12.4.1.5. Benelux

            12.4.1.6. Nordic Countries

            12.4.1.7. Rest of Europe

        12.4.2. By Services

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Services

13. Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

            13.4.1.4. Rest of Asia Pacific

        13.4.2. By Services

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Services

14. Middle East and Africa Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. GCC Countries

            14.4.1.2. South Africa

            14.4.1.3. Turkey

            14.4.1.4. Rest of Middle East and Africa

        14.4.2. By Services

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Services

15. Key Countries Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. US Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.2.1. Value Proportion Analysis by Market Taxonomy

        15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.2.2.1. By Services

    15.3. Canada Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.3.1. Value Proportion Analysis by Market Taxonomy

        15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.3.2.1. By Services

    15.4. Mexico Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.4.1. Value Proportion Analysis by Market Taxonomy

        15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.4.2.1. By Services

    15.5. Brazil Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.5.1. Value Proportion Analysis by Market Taxonomy

        15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.5.2.1. By Services

    15.6. Germany Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.6.1. Value Proportion Analysis by Market Taxonomy

        15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.6.2.1. By Services

    15.7. France Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.7.1. Value Proportion Analysis by Market Taxonomy

        15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.7.2.1. By Services

    15.8. Italy Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.8.1. Value Proportion Analysis by Market Taxonomy

        15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.8.2.1. By Services

    15.9. BENELUX Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.9.1. Value Proportion Analysis by Market Taxonomy

        15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.9.2.1. By Services

    15.10. UK Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.10.1. Value Proportion Analysis by Market Taxonomy

        15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.10.2.1. By Services

    15.11. Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.11.1. Value Proportion Analysis by Market Taxonomy

        15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.11.2.1. By Services

    15.12. China Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.12.1. Value Proportion Analysis by Market Taxonomy

        15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.12.2.1. By Services

    15.13. Japan Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.13.1. Value Proportion Analysis by Market Taxonomy

        15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.13.2.1. By Services

    15.14. South Korea Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.14.1. Value Proportion Analysis by Market Taxonomy

        15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.14.2.1. By Services

    15.15. GCC Countries Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.15.1. Value Proportion Analysis by Market Taxonomy

        15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.15.2.1. By Services

    15.16. South Africa Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.16.1. Value Proportion Analysis by Market Taxonomy

        15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.16.2.1. By Services

    15.17. Turkey Healthcare Contract Development And Manufacturing Organization Market Analysis

        15.17.1. Value Proportion Analysis by Market Taxonomy

        15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

            15.17.2.1. By Services

        15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Product footprint by Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Catalent Inc.

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Sales Footprint

            17.3.1.4. Strategy Overview

        17.3.2. Lonza Group Ltd.

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Sales Footprint

            17.3.2.4. Strategy Overview

        17.3.3. Recipharm AB

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Sales Footprint

            17.3.3.4. Strategy Overview

        17.3.4. Siegfried Holding AG

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Sales Footprint

            17.3.4.4. Strategy Overview

        17.3.5. Thermo Fisher Scientific Inc.

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Sales Footprint

            17.3.5.4. Strategy Overview

        17.3.6. Covance Inc.

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Sales Footprint

            17.3.6.4. Strategy Overview

        17.3.7. Jabil

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Sales Footprint

            17.3.7.4. Strategy Overview

        17.3.8. Sanmina Corporation

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Sales Footprint

            17.3.8.4. Strategy Overview

        17.3.9. IQVIA Holdings Inc.

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Sales Footprint

            17.3.9.4. Strategy Overview

        17.3.10. Flex

            17.3.10.1. Overview

            17.3.10.2. Product Portfolio

            17.3.10.3. Sales Footprint

            17.3.10.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 2: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 3: Global Healthcare Contract Development And Manufacturing Organization Market, By Region, 2017 – 2021

Table 4: Global Healthcare Contract Development And Manufacturing Organization Market, By Region, 2022 – 2032

Table 5: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 6: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 7: North America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

Table 8: North America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

Table 9: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 10: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 11: Latin America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

Table 12: Latin America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

Table 13: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 14: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 15: Europe Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

Table 16: Europe Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

Table 17: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 18: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 19: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

Table 20: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

Table 21: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

Table 22: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

Table 23: MEA Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

Table 24: MEA Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

Table 25: Global Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 26: Global Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 27: North America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 28: North America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 29: Latin America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 30: Latin America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 31: Europe Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 32: Europe Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 33: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 34: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 35: MEA Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

Table 36: MEA Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 - 2032

List of Figures

Figure 1: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 2: Global Healthcare Contract Development And Manufacturing Organization Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 4: Global Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

Figure 5: Global Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

Figure 6: Global Healthcare Contract Development And Manufacturing Organization Market Share, By Region, 2022 & 2032

Figure 7: Global Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 8: Global Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Region – 2022-2032

Figure 9: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 10: North America Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 11: North America Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 12: North America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

Figure 13: North America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

Figure 14: North America Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

Figure 15: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 16: North America Market Attractiveness Index, By Country – 2022-2032

Figure 17: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 18: Latin America Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 19: Latin America Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 20: Latin America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

Figure 21: Latin America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

Figure 22: Latin America Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

Figure 23: Latin America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 24: Latin America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

Figure 25: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 26: Europe Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 27: Europe Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 28: Europe Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

Figure 29: Europe Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

Figure 30: Europe Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

Figure 31: Europe Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 32: Europe Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

Figure 33: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 34: MEA Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 35: MEA Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 36: MEA Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services  – 2022-2032

Figure 37: MEA Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services  – 2022-2032

Figure 38: MEA Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

Figure 39: MEA Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: MEA Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

Figure 41: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

Figure 42: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 43: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

Figure 44: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

Figure 45: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

Figure 46: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

Figure 47: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 48: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

Figure 49: US Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 50: US Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 51: Canada Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 52: Canada Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 53: Brazil Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 54: Brazil Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 55: Mexico Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 56: Mexico Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 57: Germany Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 58: Germany Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 59: U.K. Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 60: U.K. Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 61: France Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 62: France Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 63: Italy Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 64: Italy Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 65: BENELUX Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 66: BENELUX Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 67: Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 69: China Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 70: China Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 71: Japan Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 72: Japan Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 73: South Korea Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: South Korea Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 75: GCC Countries Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 76: GCC Countries Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 77: South Africa Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 78: South Africa Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Figure 79: Turkey Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Turkey Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Copyright © Transparency Market Research, Inc. All Rights reserved